抗乙肝免疫核糖核酸
Records for this ingredient, by country (identity only).
ATC A05BA · 1 markets · 21 records
CN 21 records · 3 shown of 3
- 2 mg per mL / per unit basis not statedinjectionManufacturer: 北京赛升药业股份有限公司 ×3Manufacturer: 卫材(辽宁)制药有限公司、Manufacturer: 山西康宝生物制品股份有限公司、Manufacturer: 康普药业股份有限公司、Manufacturer: 沈阳光大制药有限公司、Manufacturer: 湖南科伦制药有限公司、Manufacturer: 西安迪赛生物药业有限责任公司、Manufacturer: 长春雷允上药业有限公司
- 1 mg per mL / per unit basis not statedinjectionManufacturer: 北京赛升药业股份有限公司 ×3Manufacturer: 大连珍奥药业股份有限公司、Manufacturer: 康普药业股份有限公司、Manufacturer: 沈阳药大雷允上药业有限责任公司、Manufacturer: 河北智同生物制药股份有限公司、Manufacturer: 西安迪赛生物药业有限责任公司
- 4 mg per mL / per unit basis not statedinjectionManufacturer: 北京赛升药业股份有限公司 ×3Manufacturer: 康普药业股份有限公司、Manufacturer: 沈阳光大制药有限公司、Manufacturer: 湖南科伦制药有限公司、Manufacturer: 通化惠康生物制药有限公司
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.